ICM
SRGA

Invenomic Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Invenomic Capital Management’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-78,452
Closed -$3.27M – 153
2021
Q2 		$3.27M Buy
78,452
+73,298
+1,422% +$3.75M 0.78% 27
2021
Q1 		$337K Buy
+5,154
New +$360K 0.08% 109

Other funds holding SRGA

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invenomic Capital Management's SRGA Position: Q3 2021 in Review

Invenomic Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2021, closing a stake of 78,452 shares — an estimated $3.27M sold.

Invenomic Capital Management first reported a position in SRGA in Q1 2021 and held it in 2 quarters. The position peaked at $3.27M in Q2 2021. 89 funds tracked by Wall St. Rank hold SRGA as of Q3 2021.

  • Invenomic Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Invenomic Capital Management sold 78,452 Surgalign Holdings, Inc. Common Stock shares in Q3 2021, an estimated $3.27M.
  • Invenomic Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Invenomic Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $3.27M in Q2 2021.
  • 89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2021.

Based on Invenomic Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.